Donna Lee Yesner represents clients in transactions, disputes, regulatory compliance, and strategic business planning relating to public healthcare programs and government contracts. Frequently representing clients in the pharmaceutical, biological, and medical device industries, Donna advises on US Federal Supply Schedule contracting, pharmaceutical research and development agreements, and matters involving suspension, debarment, and exclusion from federal programs. She also counsels companies on federal healthcare program reimbursement, drug price reporting, and compliance requirements, and their potential business impact on the companies.
Donna advises clients on issues involving the acquisition and reimbursement of US federal healthcare supplies and services, particularly contracts involving the US Department of Veterans Affairs (VA), the US Department of Defense (DOD), and the US Department of Health and Human Services (HHS). She also counsels on compliance issues relating to Medicaid, Medicare, Tricare, and the 340B drug discount programs; debarment and public policy affecting these programs; and healthcare fraud.
Additionally, Donna has represented clients in litigation and alternative dispute resolution matters before US District Courts and Courts of Appeals, boards of contract appeals, and before the US Court of Federal Claims.
Donna serves as vice-chair of the ABA Public Contracts Section Health Care Contracting Committee, and co-chair of the Coalition for Government Procurement Health Care Committee. She also publishes and lectures frequently on procurement, pricing, and reimbursement of medical supplies.
Prior to joining Morgan Lewis, Donna was a partner in the Washington, DC, office of another international law firm.
Catholic University of America, Columbus School of Law, 1983, J.D.
University of Georgia, 1977, M.A.
University of New Mexico, 1974, B.A.
District of Columbia
Awards and Affiliations
Noted in The US Legal 500 for Healthcare: Life Sciences (2014)
Listed, LMG Life Sciences Guide "Life Sciences Star" – Pricing and Reimbursement (2012–2015); Regulatory (2016–2017)
Council Member, Public Contract Law Section, American Bar Association (2001–2004)
Vice-Chair, Health Care Contracting Committee, Public Contract Law Section, American Bar Association
Co-chair, Coalition for Government Procurement, Healthcare Committee
Past Chair, Government Contracts Section, Federal Bar Association
Member, BNA Advisory Board for Pharmaceutical Law & Industry Report